CD274 and ductal breast carcinoma in situ: A thoroughly characterized cohort (n=700) of pure DCIS (n=508) and DCIS with invasive carcinoma, followed for the long term, indicated that high-density tumor-infiltrating lymphocytes (TILs), stromal FOXP3, and PDL1 are poor prognostic factors for DCIS recurrence.